Dr. Jimi Olusegun Akingbade, MD

Dr. Akingbade practices at Novant Health Outpatient Infusion at Matthews - HOPD in Matthews, North Carolina.

Dr. Akingbade's NPI, 1942269881, was assigned on March 20, 2006. Dr. Akingbade holds North Carolina license 2019-02788.

Dr. Akingbade's primary practice is Novant Health Outpatient Infusion at Matthews - HOPD, at 1500 Matthews Township Pkwy, Matthews, NC 28105.

Dr. Akingbade's primary practice is Novant Health Outpatient Infusion at Matthews - HOPD in Matthews, North Carolina. Dr. Akingbade is also affiliated with Novant Health Matthews Medical Center. The medical group on file is Novant Health Indian Land Primary Care. Dmand AI also links Dr. Akingbade to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akingbade practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Akingbade's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Akingbade's licenses on file in 3 states: North Carolina, New Jersey and Virginia.

CMS data shows 550 Medicare services from Dr. Akingbade across 10 procedure codes in 2024, for 228 Medicare patients. Medicare paid $19,829 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 228 Medicare patients who saw Dr. Akingbade in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akingbade's median patient age at 72, with 52% women.

In 2024, Dr. Akingbade wrote 683 Medicare Part D claims for 103 patients. 42% of them were for generic drugs. CMS names the drug for 622 of them, across 20 drugs with 11 or more claims each, at $162,921 in total drug cost. In 2023, CMS named 560 claims across 17 drugs.

Dr. Akingbade accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Akingbade as offering telehealth.

CMS Open Payments shows 32 general payments to Dr. Akingbade from 9 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 65% of the total. Olympus Corporation of the Americas paid the most, $1,256.